NDC properties for NDC 9 0074-4339
NDC item 00074433901
| NDC 9 | 0074-4339 |
|---|---|
| NDC 10 | 0074-4339-01 |
| NDC Item | 00074433901 |
| packaging | 1 KIT in 1 CARTON (0074-4339-01) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 1 mL in 1 PACKET |
| BLA | BLA125057 |
| Labeler | AbbVie Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2006-06-23 |
| Marketing status | ACTIVE |
NDC item 00074433902
| NDC 9 | 0074-4339 |
|---|---|
| NDC 10 | 0074-4339-02 |
| NDC Item | 00074433902 |
| packaging | 2 KIT in 1 CARTON (0074-4339-02) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 1 mL in 1 PACKET |
| BLA | BLA125057 |
| Labeler | AbbVie Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2006-06-23 |
| Marketing status | ACTIVE |
NDC item 00074433971
| NDC 9 | 0074-4339 |
|---|---|
| NDC 10 | 0074-4339-71 |
| NDC Item | 00074433971 |
| packaging | 2 KIT in 1 CARTON (0074-4339-71) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 1 mL in 1 PACKET |
| BLA | BLA125057 |
| Labeler | AbbVie Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2006-06-23 |
| Marketing status | ACTIVE |
NDC item 00074433974
| NDC 9 | 0074-4339 |
|---|---|
| NDC 10 | 0074-4339-74 |
| NDC Item | 00074433974 |
| packaging | 1 KIT in 1 CARTON (0074-4339-74) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 1 mL in 1 PACKET |
| BLA | BLA125057 |
| Labeler | AbbVie Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2006-06-23 |
| Marketing status | ACTIVE |
NDC item 50090448700
| NDC 9 | 50090-4487 |
|---|---|
| NDC 10 | 50090-4487-0 |
| NDC Item | 50090448700 |
| packaging | 2 KIT in 1 CARTON (50090-4487-0) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 1 mL in 1 PACKET |
| BLA | BLA125057 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2006-06-23 |
| Marketing status | ACTIVE |